Intra-Incisional Antibiotics for Skin Surgery

Home>
Specialties>
Dermatology>
Summary and Comment

Intra-Incisional Antibiotics for Skin Surgery

Infections after dermatologic surgery are infrequent but serious; they cause significant pain, delayed healing, and a far worse appearance of the final scar. This prospective, blinded, randomized, placebo-controlled trial evaluated the effect of intra-incisional antibiotics on the infection rate after surgical repair of 908 surgical wounds, most from Mohs micrographic surgery. The wounds were anesthetized before repair with buffered 1% lidocaine with epinephrine with or without the addition of 0.5 mg/ml of nafcillin. This concentration of nafcillin is 45 times the peak plasma concentration after a 500-mg intravenous dose. Surgical repairs included flaps, grafts, and complex layered closures.

The infection rate was 2.5% in the control group and 0.2% in the nafcillin group, a significant difference. All infections in the control group were caused by Staphylococcus aureus while the single infection in the nafcillin group was caused by Enterobacter aerogenes. The added cost of nafcillin was calculated to be less than one cent per patient.

Comment: For antibiotics to reduce infection rates they must be present in the tissue at the start of surgery. Injecting the antibiotic with the local anesthetic instantly achieves high tissue levels in the area where the antibiotic is needed most. It also reduces potential side effects because the total amount of antibiotic used is less than 0.4% of a systemic dose. However, routine use of prophylactic antibiotics against gram positive organisms may lead to the development of infections with gram negative organisms, which are often harder to treat. Intra-incisional antibiotic injection will be most useful for high-risk anatomic locations, such as the ears, or in immunosuppressed or diabetic patients.

— GJ Hruza

Published in Journal Watch Dermatology August 1, 1998

Citation(s):

Griego RD and Zitelli JA. Intra-incisional prophylactic antibiotics for dermatologic surgery. Arch Dermatol 1998 134 688-692.

Original article (Subscription may be required)
Medline abstract (Free)

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Remark subject:*

Your remark:*

Fields marked with an * are required.

Name as you'd like it to appear:
First & middle initial:*

Last:*

Email address (will not
be published):*

Professional specialty:*

Place of work (optional):

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

No competing interests

Or, the following competing interests (for example, financial stakes or professional relationships):

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.